期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Joint Optimization Scheme for the Reconfigurable Intelligent Surface-Assisted Untrusted Relay Networks
1
作者 lihua gong Wei Xu +2 位作者 Xiaoxiu Ding Nanrun Zhou Qibiao Zhu 《China Communications》 SCIE CSCD 2023年第12期19-29,共11页
To further improve the secrecy rate,a joint optimization scheme for the reconfigurable intelligent surface(RIS)phase shift and the power allocation is proposed in the untrusted relay(UR)networks assisted by the RIS.Th... To further improve the secrecy rate,a joint optimization scheme for the reconfigurable intelligent surface(RIS)phase shift and the power allocation is proposed in the untrusted relay(UR)networks assisted by the RIS.The eavesdropping on the UR is interfered by a source-based jamming strategy.Under the constraints of unit modulus and total power,the RIS phase shift,the power allocation between the confidential signal and the jamming signal,and the power allocation between the source node and the UR are jointly optimized to maximize the secrecy rate.The complex multivariable coupling problem is decomposed into three sub-problems,and the non-convexity of the objective function and the constraints is solved with semi-definite relaxation.Simulation results indicate that the secrecy rate is remarkably enhanced with the proposed scheme compared with the equal power allocation scheme,the random phase shift scheme,and the no-RIS scheme. 展开更多
关键词 iterative optimization physical layer security reconfigurable intelligent surface untrusted relay secrecy rate
下载PDF
骨纤维结构不良恶变的病例对照研究
2
作者 刘巍峰 丁宜 +5 位作者 杨勇昆 金韬 宫丽华 孙扬 郝林 牛晓辉 《中国肿瘤临床》 CAS CSCD 北大核心 2018年第19期1009-1015,共7页
目的:分析骨纤维结构不良(fibrous dysplasia,FD)恶变的生物学行为,探讨恶变诊断的危险因素。方法:回顾性分析北京积水潭医院2006年3月至2017年3月收拾的FD 394例,病理学证实恶变7例为研究组。根据恶变病例的年龄、部位等流行病学资料,... 目的:分析骨纤维结构不良(fibrous dysplasia,FD)恶变的生物学行为,探讨恶变诊断的危险因素。方法:回顾性分析北京积水潭医院2006年3月至2017年3月收拾的FD 394例,病理学证实恶变7例为研究组。根据恶变病例的年龄、部位等流行病学资料,按照1:2配对分析同期FD 14例为对照组。对比临床特点、疼痛VAS评分、病灶大小、影像学特征、血液生化指标、随访肿瘤学结果及功能评分进行统计学分析。结果:FD恶变7例,其中男性3例,女性4例。平均随访时间为175(3~396)个月,恶变后平均随访时间为26(3~51)个月。平均和中位年龄分别为45.6岁和47(24~60)岁,其中股骨6例,胫骨1例。2例为单发病灶,5例为全身多发纤维结构不良,2例为初次手术,5例为复发后确诊,恶变距初次手术间隔平均时间为207(37~377)个月。研究组的疼痛(visual analogue scale/score,VAS)评分较对照组显著增高(Z=-3.317,P=0.001),且研究组术后VAS较术前明显改善(Z=-2.384,P=0.017)。研究组较对照组术前碱性磷酸酶(alkline phosphatase,AKP)对比明显增高(Z=-2.314,P=0.021),术前乳酸脱氢酶(lac-tate dehydrogenase,LDH)(Z=-1.269,P=0.205)两组比较均无显著性差异。研究组术后AKP较术前明显下降(Z=-2.366,P=0.018),术后LDH较术前下降(Z=-2.028,P=0.043)。CT扫描发现研究组增强后CT值明显高于对照组增强后CT值(Z=-3.659,P<0.001)。单因素分析表明术前VAS评分、AKP值、皮质破坏、软组织包块和CT增强值5项因素在判断FD恶变具有临床意义。恶变病理分别为骨肉瘤4例,低级别梭形细胞肉瘤2例,未分化多形性肉瘤1例,3例患者接受辅助化疗,2例出现肺转移,1例死亡。术后功能MSTS评分,对照组平均95.0%±3.9%,功能优于研究组86.0%±10.9%(F=5.689,P=0.029)。结论:FD恶变罕见,术前VAS评分、AKP值、皮质破坏、是否存在软组织包块以及CT增强值有助于临床判断是否恶变;广泛外科边界切除为主要治疗方法。 展开更多
关键词 纤维结构不良 恶变 病例对照研究
下载PDF
Clinicopathological analysis of the periprosthetic tissue of revision total hip and knee arthroplasty
3
作者 lihua gong Xi Chen +3 位作者 Hongyi Shao Jianning Gu Rongfang Dong Yi Ding 《Chinese Medical Journal》 SCIE CAS CSCD 2023年第15期1870-1872,共3页
To the Editor:In recent years,total joint replacement has become the most effective method to preserve the joint function.However,with the increase in the numbers of surgeries,attention to post-operative complications... To the Editor:In recent years,total joint replacement has become the most effective method to preserve the joint function.However,with the increase in the numbers of surgeries,attention to post-operative complications has increased dramatically.The main complication is loosening of the prosthesis.Loosening can be caused by periprosthetic joint infection(PJI).[1]The histopathology of periprosthetic tissue is one of the commonly used methods for diagnosing PJI.Since neutrophils can reflect the body’s response to infection,the diagnosis of PJI can be determined by the neutrophil counts in the tissues. 展开更多
关键词 diagnosis INFECTION OPERATIVE
原文传递
Clinical and imaging features of phosphaturic mesenchymal tumors
4
作者 Cheng Chang Aihong Yu +6 位作者 Yuhua You Xiaoxin Peng Xiaoguang Cheng Xintong Li Wei Liang lihua gong Wei Deng 《Chinese Medical Journal》 SCIE CAS CSCD 2023年第3期351-353,共3页
To the Editor:Phosphaturic mesenchymal tumor(PMT)is a rare,slowly progressive,histomorphologically distinct entity of tumors that can emerge anywhere in the body.[1]According to World Health Organization,PMT has two p... To the Editor:Phosphaturic mesenchymal tumor(PMT)is a rare,slowly progressive,histomorphologically distinct entity of tumors that can emerge anywhere in the body.[1]According to World Health Organization,PMT has two pathological types:benign and malignant.[2]PMT was discovered due to tumor-induced osteomalacia(TIO)and is increasingly accepted in recent years as the leading cause of TIO.[1]However,most published reports have focused on the clinicopathological,immunohistochemical,and molecular genetic studies on PMT rather than the radiological work-ups.[3,4]Hence,the aim of this study was to find the common imaging characteristics of PMT to assist clinical diagnosis. 展开更多
关键词 TUMORS MESENCHYMAL TUMOR
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部